However, this strategy prevented us from including patients with untreated prostate cancer, who, in our institution, undergo [68Ga]Ga-PSMA-11-PET/MRI rather than PET/CT, and for whom participation in our study would have meant a purely study-related radiation exposure. This evidence concerns the gene FOLH1 and prostate cancer.